首页> 美国卫生研究院文献>Journal of Virology >Protection against Tetanus by Needle-Free Inoculation of Adenovirus-Vectored Nasal and Epicutaneous Vaccines
【2h】

Protection against Tetanus by Needle-Free Inoculation of Adenovirus-Vectored Nasal and Epicutaneous Vaccines

机译:通过无针接种腺病毒载体鼻和表皮疫苗预防破伤风

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effectiveness of vaccination programs would be enhanced greatly through the availability of vaccines that can be administered simply and, preferably, painlessly without the need for timed booster injections. Tetanus is a prime example of a disease that is readily preventable by vaccination but remains a major threat to public health due to the problems associated with administration of the present vaccine. Here we show that a protective immune response against live Clostridium tetani infection in mice can be elicited by an adenovirus vector encoding the tetanus toxin C fragment when administered as a nasal or epicutaneous vaccine. The results suggest that these vaccination modalities would be effective needle-free alternatives. This is the first demonstration that absorption of a small number of vectored vaccines into the skin following topical application of a patch can provide protection against live bacteria in a disease setting.
机译:可以通过简单,优选无痛注射而无需定时加强注射的疫苗来大大提高疫苗接种计划的有效性。破伤风是可以通过疫苗容易预防的疾病的主要实例,但是由于与本疫苗的施用有关的问题,仍然是对公共健康的主要威胁。在这里我们表明,当以鼻腔或表皮疫苗给药时,编码破伤风毒素C片段的腺病毒载体可以引发针对小鼠破伤风梭状芽胞杆菌感染的保护性免疫应答。结果表明,这些疫苗接种方式将是有效的无针替代品。这是第一个证明,局部应用贴剂后少量载体疫苗吸收到皮肤中可以提供针对疾病环境中活细菌的保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号